Through shared resources, such partnerships could help to make scaling processes physically and financially viable. By working to cultivate productive relationships, innovators can harness their many benefits to building powerful solutions for pressing maternal and newborn health challenges.
Innovative approaches that promote cross-sectoral partnerships for the achievement of health equity will need input from a variety of diverse partners. Effective partnerships are critical for community-based solutions for advancing health equity, making shared visions and values, increasing the community's ability to shape outcomes, and fostering multi-sectoral collaboration. To build dynamic, multi-sector partnerships, stakeholders will want to establish a framework that is built around the Healthy Aging indicators, which identify optimal health on a personal level. Public health agencies can bring data, epidemiological expertise, partnerships, and capacity for community engagement, as well as a commitment to health equity.
Strengthening health systems and capacity building requires substantial, long-term financial commitments, and it depends on intersectoral, interagency partnerships, which can be sometimes challenging to understand and sustain. In the coming years, the pressures on health systems for costs are likely to intensify, driven by both rising health care demands and macroeconomic challenges, which require deliberate prioritization and balance of initiatives over short-term and longer-term time frames.
With the level of global disease increasing, addressing the current cycle of uneven access, rising costs, and declining health outcomes requires, above all, a new approach to the traditional volume-based payment model for health care, which may serve as a constraint to effective utilization of health data and the implementation of health solutions.
When it comes to reaching meaningful scale and access, the challenge once again lies in how you marry investments and innovations built around the digital health web with attractive business models. To compete in a value-based care reimbursement environment, organizations need to take advantage of economies of scale achieved through a combination of creative partnerships, including mergers, acquisitions, clinical integration efforts, operational efficiency, and novel models of collaboration.
Innovative business models, especially those that integrate healthcare activities, have the potential to improve efficiencies, enhance care, and reduce time-wasting for consumers. Innovations in the delivery of care may lead to treatments that are more affordable, effective, and efficient, better for the current time-stressed, and increasingly empowered, healthcare consumers. In recent years, health innovators have brought us AI algorithms that arguably read x-rays from your chest better than a radiologist, low-cost genomic sequencing that can drive personalized treatment of cancer, and massive improvements to the administration of population health via big data and analytics, just to cite some examples.
Throughout the year, innovators across the sector produced inspirational examples of product, service, process, and business and delivery model innovations, often in collaboration with other sectors. National health systems are moving into regional and local markets through mergers, acquisitions, and partnerships. Many providers are working with local government agencies, social services, and faith-based organizations to achieve the shared goal of promoting population health. Innovations in data utilization and exchange are being used more often to connect partners across determinants of health in order to emphasize connections, establish a common language, and track progress in different sectors (e.g., see the Camden Healthcare Providers Alliance).
IT innovations connecting the many islands of information within a healthcare system have the potential both to dramatically increase quality and lower costs, by, for instance, keeping various providers informed about the patient and thus reducing errors of omission or commission.
Of course, universal health care is complicated and multifaceted, but it is also an exciting area for innovation, in which a multi-stakeholder model, combined with digital technologies, could underpin the sustained transformation of primary health services for all. In solving the challenges in infrastructure and networks, Resilient is leading the way to local-for-local targeted innovations in medical devices and connected care, using Resilient technologies, population-based healthcare, and virtual services, all with fair and competitive pricing. Open innovation efforts leverage crowdsourcing, competition, and partnerships to identify disruptive innovations around key healthcare problems in need of creative solutions.
For more than a decade, Takeda global Corporate Social Responsibility (CSR) programs and partnerships have made long-term commitments to strengthening healthcare systems and capacity-building across the developing world. Takeda Pharmaceutical Company Limited will continue its Global CSR Program support to the current health systems work, including in maternal, newborn, and child health, and for supply chain improvement and training of healthcare workers.
We believe in the power of strong health systems and creative partnerships to meet today's challenges, as well as prevent and prepare for what might be ahead. We cannot accomplish unlocking by ourselves, we must bring together businesses, governments, and client communities into a business model that is mutually beneficial and collaboratively sustainable.
Establishing the political will and local demand for new technologies can present a number of challenges to innovators; thus, having partnered with a local voice can help to impact the adoption and scale-up of innovations. In addition, organizations need to think about the necessary foundations for being able to rapidly scale up promising solutions developed within the facility, as well as for deploying them across the healthcare system and regions where the promised solutions are located. In the case of community-based interventions, which include a variety of sectors off affected communities, financing both the ability for all participants to engage fully in developing new leaders in communities is necessary for creating lasting changes that last beyond the funding period.
Gaining traction for emerging outcomes-based strategies such as population health is especially challenging when economic incentives and concrete downstream impacts from emerging models are hard to quantify. Because the pace of technological innovation routinely exceeds the capacity to meaningfully integrate it into operations and delivery, healthcare organizations frequently struggle with prioritizing investments and determining how technologies can achieve longer-term goals. It also can be challenging for innovators to secure financing for consumer-oriented businesses, as few mainstream health care investors have a substantial background in products and services that are sold and purchased by consumers. Another challenge is that many mainstream sources of capital are unfamiliar with the sector, making it hard to find investors, much fewer investors who might offer useful guidance for an innovator.
More often, however, these kinds of focused factories can be outperformed by managing six forces affecting healthcare innovation. The Two heads are better than one is particularly apt when it comes to global health innovation.
You must be logged in to post a comment.